# Linear Source Registry for Prostate Cancer

> **NCT02516709** · — · COMPLETED · sponsor: **CivaTech Oncology** · enrollment: 60 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Linear LDR Source

## Key facts

- **NCT ID:** NCT02516709
- **Lead sponsor:** CivaTech Oncology
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02516709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02516709, "Linear Source Registry for Prostate Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02516709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*